Skip Navigation



Rheumatology Advance Access published online on June 16, 2003

Rheumatology, doi:10.1093/rheumatology/keg356
Rheumatology © British Society for Rheumatology 2003; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/10/1202    most recent
keg356v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Al-Allaf, A. W.
Right arrow Articles by Pullar, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Allaf, A. W.
Right arrow Articles by Pullar, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Rheumatology 42 © British Society for Rheumatology 2003; all rights reserved

Original Papers

Bone health in patients with fibromyalgia

A. W. Al-Allaf 1, P. A. Mole 1, C. R. Paterson 1, and T. Pullar 2*

1 University Department of Medicine, Dundee, UK
2 Rheumatic Disease Unit, Ninewells Hospital and Medical School, Dundee, UK

* Corresponding author. E-mail: thomas.pullar{at}tuht.scot.nhs.uk.

Received 6 September 2002 ; accepted 3 March 2003

Abstract

Objectives. To determine whether women with fibromyalgia are at increased risk of developing osteoporosis or osteomalacia.

Methods. Forty premenopausal women with fibromyalgia and 37 age-matched female controls were studied. Broadband ultrasound attenuation (BUA) and velocity of sound (VOS) were measured at the calcaneum and bone mineral density was measured at the forearm and lumbar spine using dual-energy X-ray absorptiometry. Serum calcium, alkaline phosphatase, {gamma}-glutamyl transferase, 25-hydroxyvitamin D and plasma viscosity were measured in all subjects and parathyroid hormone was measured in subjects recruited in the latter part of the study.

Results. Seventeen patients with fibromyalgia syndrome and seven controls had 25-hydroxyvitamin D concentrations <20 nmol/l (P < 0.015) and in three FMS patients serum parathyroid hormone was raised. Bone density in fibromyalgia patients was slightly lower at the mid-distal forearm but comparable to that in controls at other sites.

Conclusions. There is no reason to recommend routine bone densitometry in fibromyalgia patients. However, vitamin D subnutrition is common in these patients and this should be sought.

Key words: Fibromyalgia, Bone density, Vitamin D, Osteoporosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.